The differential expression analysis results showed that the mRNA expression levels of FXYD1, ZCCHC12, and PDE2A were highly expressed in normal brain tissues, while the other six genes were significantly upregulated in glioma samples (Supplementary Figure 3B). Here, ZCCHC12 is linked to central nervous system cancer.